Sanofi Genzyme

Patent cliffs & loss of exclusivity

A corporate venture capital firm in Massachusetts that focuses on rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.

Company

Pitchbook URLhttps://pitchbook.com/profiles/investor/149417-02

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. HECTOROLDOXERCALCIFEROLSmall mol.Jun 2028
  2. HECTOROLDOXERCALCIFEROLSmall mol.Jun 2028
  3. HECTOROLDOXERCALCIFEROLSmall mol.Jun 2028
  4. HECTOROLDOXERCALCIFEROLSmall mol.
  5. HECTOROLDOXERCALCIFEROLSmall mol.
  6. RENVELASEVELAMER CARBONATESmall mol.

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Sanofi Genzyme — patent cliffs & loss of exclusivity | CliffBio